Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

NCT05983770 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant Rejection

Interventions

DRUG: AT-1501
DRUG: Tacrolimus

Sponsor

Eledon Pharmaceuticals